Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
Randomized Controlled Trial
[키워드] absence
ACTIV-4a
adaptive
adjusted
adjusted odds ratio
Analysis
anticoagulation
assigned
baseline
Bayesian
bleeding
Cohort
Complication
contribute
Controlled trial
coronavirus disease
criteria
Critical
Critically ill
defined
Enrollment
evaluated
Final
heparin
hospital discharge
Hospitalized
Ill
ill patient
IMPROVE
In-hospital death
Inflammation
initial
Major
occurred
Open-label
organ
organ support
outcome
Patient
patients who survived
Primary outcome
Probability
probability of survival
randomly assigned patient
receive
receiving
reduced
regimen
REMAP-CAP
risk of death
statistical model
survival
the patient
Thromboprophylaxis
Trial
[DOI] 10.1056/NEJMoa2105911 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1056/NEJMoa2105911 PMC 바로가기 [Article Type] Randomized Controlled Trial